New 2,6-bisheteroaryl-4-aminopyrimidine compounds are adenosine-2A receptor antagonists useful to treat e.g. acute renal failure, myocardial reperfusion injury, rhinitis, urticaria and restless leg syndrome

摘要

4-Aminopyrimidine derivatives of formula (I) FORMULA heteroaryl groups, including pharmaceutically acceptable salts thereof, wherein R1 and R2 are adenosine A2A receptor antagonists useful in the treatment of movement disorders such as Parkinson's disease.